Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_67f84d1109dc657187a664f31f9dd51f |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-198 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08 |
filingDate |
2017-10-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ac3ca90cbc69c7d3dc2990d1df4270c5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_94b62fe3a9d58773955a4524a0eb0aae http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c296fe7f9cc98c2c80c027913a5e4645 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_10b82142f3bc5136c7ba500c9d62a35c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aed5da34443d2f644b8315bdf219885d |
publicationDate |
2018-04-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2018069805-A2 |
titleOfInvention |
Method for preparation of liquid oral composition of l-thyroxin |
abstract |
The present invention discloses a processes for the preparation of a stable liquid pharmaceutical composition comprising levothyroxine or pharmaceutically acceptable salt thereof and one or more pharmaceutically acceptable excipients wherein the liquid composition of the present invention is used for oral administration. The present invention also discloses stable liquid compositions comprising levothyroxine or pharmaceutically acceptable salt thereof and one or more pharmaceutically acceptable excipients prepared according to the processes of the present invention. |
priorityDate |
2016-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |